Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 15 | 2018 | 349 | 2.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 24 | 2020 | 1437 | 2.010 |
Why?
|
| Brain | 18 | 2018 | 965 | 1.850 |
Why?
|
| Cognition | 13 | 2020 | 547 | 1.450 |
Why?
|
| Aging | 8 | 2015 | 942 | 1.380 |
Why?
|
| Auditory Perception | 8 | 2009 | 80 | 1.060 |
Why?
|
| Attention | 6 | 2009 | 84 | 1.000 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2018 | 1223 | 0.910 |
Why?
|
| Visual Perception | 7 | 2009 | 121 | 0.770 |
Why?
|
| Caloric Restriction | 2 | 2019 | 92 | 0.690 |
Why?
|
| Neuropsychological Tests | 12 | 2019 | 327 | 0.580 |
Why?
|
| Aged | 30 | 2020 | 10260 | 0.550 |
Why?
|
| Exercise | 2 | 2019 | 603 | 0.540 |
Why?
|
| Obesity | 3 | 2019 | 1111 | 0.540 |
Why?
|
| Exercise Therapy | 1 | 2019 | 250 | 0.510 |
Why?
|
| Female | 35 | 2020 | 19942 | 0.440 |
Why?
|
| Humans | 41 | 2020 | 32274 | 0.420 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 72 | 0.410 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2013 | 3 | 0.410 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 51 | 0.390 |
Why?
|
| Middle Aged | 26 | 2020 | 11848 | 0.390 |
Why?
|
| Pain | 1 | 2015 | 303 | 0.390 |
Why?
|
| Mobility Limitation | 1 | 2014 | 208 | 0.370 |
Why?
|
| African Americans | 8 | 2018 | 1335 | 0.370 |
Why?
|
| Male | 30 | 2019 | 19437 | 0.370 |
Why?
|
| Adult | 19 | 2016 | 9256 | 0.360 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 27 | 0.350 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 143 | 0.340 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 427 | 0.330 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 280 | 0.320 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2007 | 103 | 0.310 |
Why?
|
| Sensation | 1 | 2009 | 60 | 0.290 |
Why?
|
| Dementia | 3 | 2015 | 246 | 0.280 |
Why?
|
| Acoustic Stimulation | 7 | 2009 | 121 | 0.280 |
Why?
|
| Cues | 4 | 2009 | 65 | 0.280 |
Why?
|
| Photic Stimulation | 7 | 2009 | 167 | 0.280 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 293 | 0.280 |
Why?
|
| Brain Mapping | 5 | 2014 | 190 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2008 | 178 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 132 | 0.250 |
Why?
|
| Risk Factors | 8 | 2018 | 3934 | 0.210 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2015 | 216 | 0.210 |
Why?
|
| European Continental Ancestry Group | 6 | 2018 | 1076 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 1050 | 0.190 |
Why?
|
| Genotype | 3 | 2020 | 702 | 0.190 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 1479 | 0.190 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 543 | 0.190 |
Why?
|
| Brain Diseases | 2 | 2014 | 31 | 0.190 |
Why?
|
| Reaction Time | 5 | 2009 | 123 | 0.190 |
Why?
|
| Organ Size | 5 | 2018 | 221 | 0.190 |
Why?
|
| Albuminuria | 4 | 2017 | 172 | 0.180 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 3898 | 0.170 |
Why?
|
| Life Style | 2 | 2020 | 393 | 0.160 |
Why?
|
| Diabetes Complications | 3 | 2018 | 171 | 0.160 |
Why?
|
| Models, Neurological | 2 | 2014 | 139 | 0.160 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 146 | 0.160 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 56 | 0.160 |
Why?
|
| Auditory Cortex | 3 | 2009 | 21 | 0.160 |
Why?
|
| Cohort Studies | 7 | 2018 | 1840 | 0.150 |
Why?
|
| Blood Glucose | 3 | 2019 | 484 | 0.150 |
Why?
|
| Analysis of Variance | 3 | 2009 | 471 | 0.150 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1158 | 0.150 |
Why?
|
| Executive Function | 1 | 2019 | 52 | 0.150 |
Why?
|
| Menopause | 1 | 2020 | 109 | 0.150 |
Why?
|
| Task Performance and Analysis | 2 | 2009 | 50 | 0.150 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2015 | 157 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2018 | 173 | 0.130 |
Why?
|
| Weight Loss | 1 | 2020 | 410 | 0.130 |
Why?
|
| Overweight | 1 | 2018 | 252 | 0.120 |
Why?
|
| Postmenopause | 2 | 2015 | 424 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 87 | 0.120 |
Why?
|
| Young Adult | 3 | 2014 | 2648 | 0.120 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 4 | 0.120 |
Why?
|
| Spectrin | 1 | 2014 | 5 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 12 | 0.110 |
Why?
|
| Prevalence | 2 | 2018 | 955 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2015 | 66 | 0.110 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 49 | 0.110 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 40 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 821 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 4 | 2017 | 302 | 0.110 |
Why?
|
| Anxiety | 1 | 2015 | 190 | 0.100 |
Why?
|
| Dopamine | 1 | 2016 | 262 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 93 | 0.100 |
Why?
|
| Tomography, Spiral Computed | 1 | 2013 | 19 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 223 | 0.100 |
Why?
|
| Nerve Net | 1 | 2014 | 137 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 757 | 0.090 |
Why?
|
| Depression | 1 | 2015 | 420 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2016 | 727 | 0.090 |
Why?
|
| Visual Cortex | 2 | 2009 | 46 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2013 | 146 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3416 | 0.090 |
Why?
|
| United States | 6 | 2018 | 4072 | 0.090 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 15 | 0.090 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2011 | 36 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 45 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 773 | 0.080 |
Why?
|
| Fatty Acid Desaturases | 1 | 2011 | 51 | 0.080 |
Why?
|
| Computational Biology | 1 | 2011 | 99 | 0.080 |
Why?
|
| Prognosis | 1 | 2014 | 1534 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 534 | 0.080 |
Why?
|
| Science | 1 | 2010 | 8 | 0.080 |
Why?
|
| Social Responsibility | 1 | 2010 | 14 | 0.080 |
Why?
|
| Ethics, Research | 1 | 2010 | 25 | 0.080 |
Why?
|
| Teaching | 1 | 2010 | 60 | 0.080 |
Why?
|
| Research | 1 | 2010 | 81 | 0.080 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 6 | 0.080 |
Why?
|
| Noise | 1 | 2009 | 7 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2013 | 417 | 0.070 |
Why?
|
| Space Perception | 1 | 2009 | 30 | 0.070 |
Why?
|
| Environment | 1 | 2009 | 47 | 0.070 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 8 | 0.070 |
Why?
|
| Laboratories | 1 | 2008 | 18 | 0.070 |
Why?
|
| Behavior | 1 | 2008 | 29 | 0.070 |
Why?
|
| Heterozygote | 2 | 2020 | 60 | 0.070 |
Why?
|
| Curriculum | 1 | 2010 | 203 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 108 | 0.070 |
Why?
|
| Adolescent | 4 | 2009 | 3517 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 232 | 0.070 |
Why?
|
| Sensory Thresholds | 1 | 2007 | 28 | 0.070 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2007 | 5 | 0.070 |
Why?
|
| Mental Processes | 1 | 2007 | 15 | 0.070 |
Why?
|
| Echo-Planar Imaging | 1 | 2007 | 14 | 0.070 |
Why?
|
| Perception | 1 | 2007 | 99 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1179 | 0.060 |
Why?
|
| Creatinine | 2 | 2017 | 191 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 425 | 0.060 |
Why?
|
| Diabetic Angiopathies | 2 | 2015 | 150 | 0.050 |
Why?
|
| Hypertension | 3 | 2017 | 979 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 101 | 0.050 |
Why?
|
| Risk | 2 | 2015 | 305 | 0.050 |
Why?
|
| Animals | 1 | 2015 | 8199 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 541 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2011 | 14 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2011 | 211 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 76 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 141 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 217 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2019 | 242 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 119 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2018 | 102 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 170 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2016 | 9 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 863 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 136 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 651 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 83 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 73 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2015 | 112 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 112 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 2204 | 0.030 |
Why?
|
| Stroop Test | 1 | 2014 | 4 | 0.030 |
Why?
|
| Memory | 1 | 2016 | 202 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 160 | 0.030 |
Why?
|
| Albumins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 46 | 0.030 |
Why?
|
| Estrogens | 1 | 2015 | 194 | 0.030 |
Why?
|
| Smoking | 1 | 2017 | 505 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 854 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 167 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2014 | 114 | 0.020 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 18 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 621 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 169 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1241 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1300 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 23 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 32 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 24 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 50 | 0.020 |
Why?
|
| Family Health | 1 | 2011 | 73 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 181 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 883 | 0.020 |
Why?
|
| Education, Graduate | 1 | 2010 | 4 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2240 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 62 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 623 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 273 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 2 | 0.020 |
Why?
|
| Sample Size | 1 | 2007 | 38 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 238 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 116 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2007 | 251 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2007 | 187 | 0.010 |
Why?
|